| Literature DB >> 27821953 |
Hidemasa Iki1, Shunji Sawa1, Toshio Teranishi1, Masao Tomita1, Kazuhiro Nishii1, Kouji Yamada1.
Abstract
[Purpose] The number of bedridden patients requiring nursing care in Japan has increased sharply in recent years because of its aging population and advances in medical care and has become a major social issue. Because bedridden patients are susceptible to nursing and healthcare-associated pneumonia, it is very important to improve their immunocompetence. Therefore, the effect of exercise therapy on stimulation of cytokine secretion in the saliva of bedridden patients was investigated.Entities:
Keywords: Bedridden patients; Interleukin; Nursing and healthcare-associated pneumonia (NHCAP)
Year: 2016 PMID: 27821953 PMCID: PMC5088144 DOI: 10.1589/jpts.28.2871
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Demographics of subjects for known myokines
| Demographics | |
|---|---|
| Total subjects (n) | 21 |
| Age (years) | 87.2 ± 6.5 |
| Etiology (n) | Cerebral infarction, 15 Cerebral haemorrhage, 4 Hydrocephalus, 2 |
| Time since onset (months) | 31.2 ± 16.7 |
| Time out of bed (hours/week) | 3.9 ± 3.9 |
Changes in vital signs
| Blood pressure (mmHg) | Pulse rate (bpm) | Respiration rate (bpm) | |
|---|---|---|---|
| BE | 116.0 ± 21.4 | 72.6 ± 10.8 | 18.9 ± 4.8 |
| AEsi | 131.2 ± 19.5*, ** | 81.1 ± 14.3*, ** | 23.4 ± 6.4***, **** |
| AEsu | 123.5 ± 21.8** | 74.8 ± 9.5 | 21.3 ± 5.1*, **** |
| AE | 115.4 ± 19.3 | 71.5 ± 10.0 | 19.1 ± 4.6 |
BE: before the start of exercise therapy; AE: after the end of exercise; AEsi: after 5 minutes of exercise therapy while sitting; AEsu: after 5 minutes of exercise therapy while supine. *Significant (p<0.05) difference between BE and Aesi or Aesu. **Significant (p<0.05) difference between AE and Aesi or Aesu. ***Significant (p<0.001) difference between BE and Aesi or Aesu. ****Significant (p<0.001) difference between AE and Aesi or Aesu
Changes in the relative levels of three kinds of IL
| IL-6 | IL-8 | IL-15 | |
|---|---|---|---|
| 0 h | 1.0 | 1.0 | 1.0 |
| 0.5 h | 1.5 ± 0.9 | 1.1 ± 0.4 | 1.5 ± 1.2 |
| 1 h | 1.3 ± 0.9 | 1.2 ± 0.9 | 1.3 ± 1.0 |
| 3 h | 1.7 ± 1.3 | 1.2 ± 0.6 | 1.5 ± 1.1 |
0 h, before the start of exercise; 0.5 h, 0.5 h after the end of exercise; 1 h after the end of exercise; 3 h after the end of exercise
Comparison of frequency of appearance of maximum IL values
| IL-6 | IL-8 | IL-15 | |
|---|---|---|---|
| 0 h (n) | 4 | 4 | 4 |
| 0.5 h (n) | 6 | 2 | 5 |
| 1 h (n) | 3 | 5 | 5 |
| 3 h (n) | 8 | 3 | 5 |
Comparison of maximum values and values at 0 h
| IL-6 | IL-8 | IL-15 | |
|---|---|---|---|
| 0 h | 1 | 1 | 1 |
| Maximum values | 2.7 ± 2.4* | 1.2 ± 0.3* | 2.1 ± 1.4* |
*p<0.05
Demographics of subjects for IL-17 and IL-22
| Demographics | |
|---|---|
| Total subjects (n) | 14 |
| Age (years) | 86.8 ± 7.3 |
| Etiology (n) | Cerebral infarction, 9 Cerebral haemorrhage, 3 Hydrocephalus, 2 |
| Time since onset (months) | 29.9 ± 11.9 |
| Time out of bed (hours/week) | 3.5 ± 3.5 |
Changes in the relative levels of IL-17
| IL-17 | |
|---|---|
| 0 h | 1.0 |
| 0.5 h | 3.1 ± 2.4 |
| 1 h | 4.1 ± 3.4 |
| 3 h | 2.6 ± 2.5 |
0 h, before the start of exercise; 0.5 h, 0.5 h after the end of exercise; 1 h after the end of exercise; 3 h after the end of exercise
Comparison of maximum values and values at 0 h
| IL-17 | |
|---|---|
| 0 h | 1 |
| Maximum values | 5.2 ± 2.9* |
*p<0.001